Anonymous
Guest
Anonymous
Guest
I would submit the following reasons:
1. The insular culture at the highest levels of the US organization
2. The drastic pay differential
3. The lack of promotional opportunities
4. Inadequate mentoring and retention programs to identify and promote top talent
The mass exodus of minority employees will be a long-term disadvantage with an extremely diverse customer and patient population. Basel should take note of the talent pipeline shortfall that is happening under current US Pharma leadership.
1. The insular culture at the highest levels of the US organization
2. The drastic pay differential
3. The lack of promotional opportunities
4. Inadequate mentoring and retention programs to identify and promote top talent
The mass exodus of minority employees will be a long-term disadvantage with an extremely diverse customer and patient population. Basel should take note of the talent pipeline shortfall that is happening under current US Pharma leadership.